Placenta: When the past informs our future
Your belly button is the last reminder of arguably the most fascinating yet fleeting organ you ever had: the placenta. Simultaneously taking on the role of lungs, liver, gut and kidneys, this temporary structure develops during pregnancy to provide the fetus with oxygen and nutrients while also removing waste products (Burton and Fowden, 2015). The placenta also features the maternal-fetal interface, where the cells of the mother and the fetus work together to develop the structures and avenues of communication necessary for a successful pregnancy. Disrupting this process can result in complications such as preeclampsia or preterm birth, which affects around 15 million pregnancies worldwide every year (Blencowe et al., 2012; Erlebacher, 2013).
Yet, it is almost impossible to safely study the maternal-fetal interface during pregnancy: instead, researchers can turn to its evolutionary history. Indeed, how the interface came to be is inseparable from the way it operates and malfunctions today. In particular, comparing and contrasting this process across diverse species can highlight innovations in specific pathways or genes. Now, in eLife, Vincent Lynch and colleagues – including Mirna Marinić as first author, Katelyn Mika and Sravanthi Chigurupati – report on using this approach to identify the genes that the maternal-fetal interface needs to form and work properly in placental animals (Marinić et al., 2021).
Marinić et al. – who are based at the University of Buffalo, the University of Chicago and AbbVie – gathered gene expression data from the maternal side of the maternal-fetal interface from 28 species ranging from frogs to people. Of the 20,000 genes studied, just 149 had placental expression which, when mapped onto the evolutionary tree, suggested that these genes had started to be expressed at the maternal-fetal interface when placental structures first emerged.
One of the 149 genes, known as HAND2 (short for heart and neural crest derivatives-expressed protein 2), encodes a regulatory protein that contributes to the embryo getting implanted into the wall of the uterus (Mestre-Citrinovitz et al., 2015). However, it has also been associated with preterm birth, and could be important later on for a healthy pregnancy (Brockway et al., 2019).
To understand how HAND2 is involved in the later stages of pregnancy, Marinić et al. used short-tailed opossum data and human cell cultures to create a model for the role of this gene at the maternal-fetal interface. The experiments revealed that HAND2 regulates IL15, a gene that encodes a cytokine – a type of small signaling protein that helps to regulate the activity of the immune system. While it was once thought that the maternal immune system was turned down to accommodate the ‘foreign cells’ of a fetus, scientists now know that it actively helps to establish and maintain a healthy pregnancy (Racicot et al., 2014). In particular, the immune system may contribute to triggering the onset of birth.
Marinić et al. discovered that early in pregnancy, HAND2 is present at high levels at the maternal-fetal interface. In turn, this increases the local expression of IL15, which then recruits natural killer cells, a component of the immune system that shapes the maternal-fetal interface. As pregnancy progresses, the expression of HAND2 and IL15 decreases; this might aid in the correct timing of birth by reducing levels of natural killer cells at the interface (Figure 1C).

Studying evolution to understand the genes that shape the maternal-fetal interface.
(A) The expression of HAND2 (large red circles) was measured at the maternal-fetal interface across multiple placental and non-placental species. Marinić et al. then used ancestral reconstruction to infer that the expression of HAND2 (small red circles) at the maternal-fetal interface arose in the ancestor of all placental mammals (shown in purple). In the wallaby, the expression of HAND2 has a distinct evolutionary origin, which is most likely associated with other derived pregnancy traits in this species. (B) The placenta (fetal; purple) and uterine wall (maternal; gray) meet at the maternal-fetal interface, where nutrients and waste are exchanged, and communication systems are established. (C) During early pregnancy, HAND2 is highly expressed at the maternal-fetal interface: the resulting increase in IL15 expression leads to immune natural killer cells (NK cells) being recruited to the interface (top), where they help to shape the structure. As pregnancy progresses, decreased HAND2 and IL15 expression alters the recruitment of NK cells, which may have a role in determining when birth should start.
To help diagnose, treat and prevent pregnancy disorders, we must first understand the tightly choreographed ballet of cells and communication signals that sustains healthy gestation. Examining the differences in gene expression between humans and closely related species helps to uncover new elements of this careful dance. By looking back at our past, Marinić et al. work to prevent future preterm births.
References
-
The placenta: a multifaceted, transient organPhilosophical Transactions of the Royal Society B: Biological Sciences 370:20140066.https://doi.org/10.1098/rstb.2014.0066
-
Immunology of the maternal-fetal interfaceAnnual Review of Immunology 31:387–411.https://doi.org/10.1146/annurev-immunol-032712-100003
-
Understanding the complexity of the immune system during pregnancyAmerican Journal of Reproductive Immunology 72:107–116.https://doi.org/10.1111/aji.12289
Article and author information
Author details
Publication history
- Version of Record published: March 9, 2021 (version 1)
Copyright
© 2021, LaBella
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 901
- Page views
-
- 87
- Downloads
-
- 1
- Citations
Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Evolutionary Biology
- Microbiology and Infectious Disease
Drug resistance remains a major obstacle to malaria control and eradication efforts, necessitating the development of novel therapeutic strategies to treat this disease. Drug combinations based on collateral sensitivity, wherein resistance to one drug causes increased sensitivity to the partner drug, have been proposed as an evolutionary strategy to suppress the emergence of resistance in pathogen populations. In this study, we explore collateral sensitivity between compounds targeting the Plasmodium dihydroorotate dehydrogenase (DHODH). We profiled the cross-resistance and collateral sensitivity phenotypes of several DHODH mutant lines to a diverse panel of DHODH inhibitors. We focus on one compound, TCMDC-125334, which was active against all mutant lines tested, including the DHODH C276Y line, which arose in selections with the clinical candidate DSM265. In six selections with TCMDC-125334, the most common mechanism of resistance to this compound was copy number variation of the dhodh locus, although we did identify one mutation, DHODH I263S, which conferred resistance to TCMDC-125334 but not DSM265. We found that selection of the DHODH C276Y mutant with TCMDC-125334 yielded additional genetic changes in the dhodh locus. These double mutant parasites exhibited decreased sensitivity to TCMDC-125334 and were highly resistant to DSM265. Finally, we tested whether collateral sensitivity could be exploited to suppress the emergence of resistance in the context of combination treatment by exposing wildtype parasites to both DSM265 and TCMDC-125334 simultaneously. This selected for parasites with a DHODH V532A mutation which were cross-resistant to both compounds and were as fit as the wildtype parent in vitro. The emergence of these cross-resistant, evolutionarily fit parasites highlights the mutational flexibility of the DHODH enzyme.
-
- Evolutionary Biology
- Neuroscience
The process of brain folding is thought to play an important role in the development and organisation of the cerebrum and the cerebellum. The study of cerebellar folding is challenging due to the small size and abundance of its folia. In consequence, little is known about its anatomical diversity and evolution. We constituted an open collection of histological data from 56 mammalian species and manually segmented the cerebrum and the cerebellum. We developed methods to measure the geometry of cerebellar folia and to estimate the thickness of the molecular layer. We used phylogenetic comparative methods to study the diversity and evolution of cerebellar folding and its relationship with the anatomy of the cerebrum. Our results show that the evolution of cerebellar and cerebral anatomy follows a stabilising selection process. We observed 2 groups of phenotypes changing concertedly through evolution: a group of 'diverse' phenotypes - varying over several orders of magnitude together with body size, and a group of 'stable' phenotypes varying over less than 1 order of magnitude across species. Our analyses confirmed the strong correlation between cerebral and cerebellar volumes across species, and showed in addition that large cerebella are disproportionately more folded than smaller ones. Compared with the extreme variations in cerebellar surface area, folial anatomy and molecular layer thickness varied only slightly, showing a much smaller increase in the larger cerebella. We discuss how these findings could provide new insights into the diversity and evolution of cerebellar folding, the mechanisms of cerebellar and cerebral folding, and their potential influence on the organisation of the brain across species.